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 Microdialysis is a diffusion-based sampling method that can be useful for monitoring 
various biological systems.  Matrix metalloproteinases are a class of enzymes responsible for 
remodeling the extracellular matrix that, when dysregulated, are linked to various diseases. The 
delivery method of microdialysis is of particular interest as a sampling technique for enzymatic 
reactions. Microdialysis was performed in vitro using a model enzyme, porcine pancreatic 
elastase, because it is a useful substitute for matrix metalloproteinases. A colorimetric substrate 
for elastase, succinyl-ala-ala-ala-p-nitroanilide, and its product p-nitroaniline were measured 
using a UV-Vis spectrophotometer. Using an expanded Beer’s Law equation, both analytes’ 
concentrations were determined simultaneously from one dialysate sample using two of their 
overlapping absorbance wavelengths. The experiment aimed to test the effect flow rate, 
enzymatic solution concentration, and substrate concentration had upon the extraction efficiency 
of the procedure. Flow rate manipulations were consistent with literature, with higher flow rates 
yielding lower extraction efficiencies. Increasing the elastase concentration showed an increase 
in extraction efficiency of the substrate, whereas increasing the substrate concentration had no 
apparent effect on the extraction efficiency. Increasing either elastase or Succ-(Ala)3-p-NA 





I. i. Overview:  
Extracellular matrix (ECM) remodeling by proteases called matrix metalloproteinases 
(MMPs) is a critically important process that functions normally in embryogenesis or 
homeostasis, but potentially can become dysregulated leading to various self-destructive disease 
states. This class of 23 endopeptidases serves to remodel extracellular matrix proteins, such as 
collagen and elastase, plays a role in embryonic development, and studies have linked 
upregulated MMP concentrations to various disease states including arthritis, cancer and wound 
healing.1, 2 Typically, many MMPs are activated simultaneously, thus monitoring the in vivo 
activity would be of clinical significance in recognizing when a patient may be at risk of 
dysregulated MMP activity.5 Current methods to monitor the activity of MMPs include 
zymography, requiring extraction of whole tissue and a lengthy monitoring of both active and 
inactive forms of the enzymes1, and immunochemical methods, though quantitative, cannot 
distinguish between active and pro-enzyme forms of the proteins.4 Colorimetric assays are also 
used, however are limited by the fluorescent tags available and require LC MS procedures to 
distinguish. However, microdialysis sampling, used with judicious choices of substrates and an 
appropriate mathematical model, may allow for accurate monitoring of in vivo MMP activity in 
real time.  
I. ii. Microdialysis Sampling 
Microdialysis is a widely-used, minimally invasive, in vivo method to collect chemical 
components in tissue.6 The process is performed using small probes with a 4-10 mm semi-
permeable membrane tip of a specific molecular weight cutoff (MWCO), allowing size selective 
passage of molecules to diffuse in or out. A perfusion fluid, matching the sample solution’s ionic 
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strength and chemical moiety, is loaded into a syringe and pumped through the inner membrane 
lumen at typical flow rates of 0.5-2.0 µL/min into a sample solution.6 Analytes can also diffuse 
from the sample medium into the probe through a diffusion gradient as well. The target analytes, 
following diffusion into the probe, and any remaining perfusate travel through the outlet, as 
dialysate fluid, into a collection vial.7-10 This process is summarized in Figure 1. 
 
Microdialysis as a sampling method holds several advantages to its usage. The size, 
usually 200-500 µm in diameter and 1-30 mm in length, allows minimally invasive in vivo 
sampling, with applications that began with studies in rat brain biochemistry to human studies of 
various organ systems.6, 11 Another benefit comes from the semi-selectivity offered by the semi-
permeable membrane. Depending on the probe’s MWCO, a generic local sampling can be 
performed which could allow macromolecular sampling of proteins or selective sampling of low 
molecular weight compounds such as neurotransmitters or glucose. This provides a versatile 







Since microdialysis is often a function of variables like membrane length, membrane 
material, membrane MWCO, and diffusion coefficients, the extraction efficiency (EE) of 
microdialysis is usually displayed as a percentage, using Equation 1, to provide quantification of 
the probe’s sampling efficiency.4, 6 In this equation, Coutlet refers to the concentration of analyte 
collected as dialysate, Cinlet refers to the concentration of analyte present in the perfusate, and 
Csample refers to the far-field concentration of analyte outside of the probe.  
EE = !!"#$%#!!!"#$%
!!"#$%&!!!"#$%
 × 100%             (1) 
By manipulating these concentrations, the extraction efficiency equation can be further modified 
into relative recovery (Equation 2), in which Cinlet is 0 and Csample is assumed a finite amount, or 
delivery (Equation 3), in which Csample is set to 0 and Cinlet is a finite amount. Recovery is useful 
for quantifying the effectiveness of microdialysis as a sampling tool for an unknown 
concentration of analyte in solution, whereas delivery (also known as loss) is beneficial in 
pharmacokinetic and activity assays of enzymes by introducing enzymatic substrate via the 
perfusate fluid into an enzymatic solution.  
Relative Recovery = EE!"# =
!!"#$%#
!!"#$%&
 × 100%                (2) 
Relative Delivery = EE!"## =
!!"#$%#!!!"#$%
!!!"#$%
 × 100%                         (3) 
The delivery method of microdialysis is of interest because the coupling of size-selective 
permeability of the probe and proper analysis techniques of dialysate can allow local monitoring 
of in situ biological processes by instigating biochemical processes, such as an MMP reaction, by 
delivery of substrate and analysis of the recovered products with increased temporal resolution. 
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I. iii. Usage of an in vitro Enzymatic Model System 
Sourcing MMPs is quite expensive, and as previously stated, they exist naturally as a mixture of 
MMP subtypes in a zymogen form until activated.1, 4, 5 Because of this, it is difficult to perform controlled 
cost-efficient in vivo studies regarding MMPs. For this study, and many others preceding it,1, 4, 5 porcine 
pancreatic elastase (PPE) is used as a useful model enzyme since it has the same substrate specificity as 
MMP-12, but at a fraction of the cost. Though all 23 MMPs are of clinical significance, MMP-12, or 
macrophage elastase, is one of interest due to it implication in emphysemas, abdominal aortic aneurysms, 
and atherosclerosis.2 This MMP cleaves extracellular matrix proteins such as elastin, collagen, and fibrins 
normally, but can, when dysregulated, lead to the weakening of vital cardio-respiratory tissues due to this 
unregulated cleaving mechanism. Therefore despite PPE being used as preliminary model for one MMP, 
the MMP in question still has clinical relevance in developing a suitable sampling method.  
PPE cleaves a colorimetric substrate, succinyl-trialanine-p-nitroanilide (Succ-(Ala)3-p-NA), into 
the product p-nitroaniline (p-NA) and has been previously described for microdialysis studies by the 
Stenken group (Figure 2).6 Due to the colorimetric metabolic product, UV-Vis spectrophotometry can be 
then used to quantify the recovered product and the EE of the delivered substrate as a method of 











I. iv. UV-Vis Spectrophotometry 
Initially microdialysis was limited in its utility due to detection limitations requiring 50-
100 µL samples to gain any appreciable readings of dialysate.6 However, with current advances 
in analysis methods, this no longer acts as major impedance for microdialysis studies. A 
commonly used method to determine solution concentrations is spectrophotometry. Using Beer’s 
Law (Equation 4), the absorbance of a chemical is directly proportional to the chemical’s 
concentration, [X], its molar absorptivity, ε!, and the path length, b (usually in values of 1 so as 
to be negligible).12 
   A = ε!b[X]                          (4) 
Thus, Beer’s Law allows the use of spectrophotometry to quantify dilute solutions such as the 
dialysate of a microdialysis sampling procedure. Thermo-Fischer’s NanoDrop 2000c model is 
particularly useful in this regard as it can reliably measure the absorbance of aliquots as small as 
1-2 µL in volume, a convenient amount since microdialysis collects at 0.5 to 2 µL/min rates 
normally. The low aliquot size for the NanoDrop eliminates one of the largest burdens with 
microdialysis, that being the time necessary to accumulate enough dialysate to make analytical 
measurements.  
 Substances have a maximum absorbance wavelength (λmax) where the largest light 
absorbance occurs, however they can and will still absorb over a range of nearby wavelengths as 
well. In this experiment, a colorimetric substrate, Succ-(Ala)3-p-NA, is cleaved into p-NA, 
however their maximum absorbance wavelengths overlap, and since they both will be present in 
the dialysate, the measurements at their respective maxima will not be sufficient to quantify their 
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concentrations as each chemical will contribute at each wavelength. This is because absorbance 
is an additive quantity, as expressed by equation 5.12 
A! =  ε!! b X +  ε!! b Y  
A!! =  ε!!!b X +  ε!!!b Y                            (5) 
In the above equations, A! refers to the total absorbance read by a spectrophotometer at one 
wavelength, a value made up of the Beer’s law calculated absorbance for two separate chemicals, 
X and Y. Their combined absorbance makes up the absorbance measured by the 
spectrophotometer. A!! refers to the total absorbance at another wavelength. Each of these 
equations use different molar absorptivities specific to the chemical at that specific wavelength 
the spectrophotometer is measuring. Thus standards of each chemical can be produced to 
develop a calibration curve at both absorbance maximum wavelengths to determine their molar 
absorptivity. Since each quantity but the concentrations are known, a system of equations is 
possible using equation 6.12 
    X =  
!! !!! !
!!! !!!!!
!!! ! !!! !
!!!!! !!!!!
           [Y] =
!!! ! !!
!!!!! !!!
!!! ! !!! !
!!!!! !!!!!
                              (6) 
The concentrations of p-NA and Succ-(Ala)3-p-NA in the dialysate can thus be individually 
calculated in this method by solving the determinants present in the above equation after 




II. Materials and Methods 
II. i. Chemicals and Equipment 
 The enzyme, elastase from porcine pancreas (E1250), its substrate, N-succinyl-L-Ala-
Ala-Ala -p-nitroanilide (S4760), and its colorimetric product, 4-nitroaniline (N2128) were 
purchased from Sigma Aldrich (St. Louis, MO). A 2 mM stock of Succ-(Ala)3-p-NA in 10 mM 
PBS (pH=7.4) was produced from the Sigma solid; daily substrate solutions were diluted from 
this 2 mM solution for experimentation. Enzyme solutions were produced daily from the Sigma 
stock solution into a 10 mM PBS buffer (pH=7.4). For microdialysis, CMA/20 probes (MWCO 
20 kDa) were purchased from Harvard Apparatus (Holliston, MA). The pumps (MD-1000), 
drivers (MD-1001), and 1 mL syringes (MDN-0100) used for microdialysis were purchased from 
BASi (West Lafayette, IN). Spectrophotometric analysis of the solutions was performed using a 
NanoDrop 2000c purchased from Thermo Fisher (Pittsburgh, PA).  
II. ii. Formation of Calibration Curves for Substrate and Product 
 A 2 mM Succ-(Ala)3-p-NA stock solution in 10 mM phosphate buffered saline at 7.4 pH 
was produced, from which a 1000 µM standard was pulled to determine the maximum 
absorbance wavelength of Succ-(Ala)3-p-NA.  Standards were also created for p-NA in this same 
manner. PBS was used to obtain the blank for the NanoDrop, and full UV-Vis absorbance scans 
were collected to determine the maximum absorbance wavelengths for Succ-(Ala)3-p-NA and p-
NA. From this reading, the largest absorbance peaks were selected for both chemicals, 
correlating to 315 nm for Succ-(Ala)3-p-NA and 380 nm for p-NA. However, it was noted that 
the absorbance curves overlapped slightly for both chemicals at these wavelengths. 
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 To produce calibration curves for the NanoDrop, the 1000 µM solutions were serially 
diluted to 500, 250, 125, 62.5, 31.25, and 15.625 µM solutions. These solutions were then 
analyzed within the NanoDrop in triplicate 2 µL aliquots at both 315 and 380 nm absorbance 
readings. This data was averaged and fitted with a linear trend in Excel to provide a calibration 
curve at each wavelength for both Succ-(Ala)3-p-NA and p-NA. Beer’s Law at a path length of 1 
mm was used to determine the molar absorptivity of Succ-(Ala)3-p-NA and p-NA at both 315 
and 380 nm wavelengths using these calibration curves. 
II. iii. Microdialysis Sampling 
 Microdialysis sampling experiments were performed several times while adjusting 
variables such as pump flow rate, enzyme concentration, and substrate concentration. The 
sampling technique used three CMA/20 probes (each having a 20 kDa MWCO) submerged in 
three 2 mL solutions of enzyme so as to fully cover the semi-permeable membrane of the probes. 
A pump delivered Succ-(Ala)3-p-NA through the membrane inner lumen into the enzyme 
solution as perfusate allowing collection of p-NA and unreacted Succ-(Ala)3-p-NA as dialysate. 
The pump perfused Succ-(Ala)3-p-NA, loaded into three syringes, through the attached probes 
for a set amount of time so as to collect approximately 10 µL of dialysate. The probes were 








 The first experiment tested the fluid delivery of HPLC water from the pump and syringes 
using FEP tubing into collection vials to ensure calibration of the equipment. The pump was set 
to 3 µL/min perfusion, and fluid was collected for 5 minutes. Using gravimetric analysis, the 
volume of the delivered fluid was determined and compared to the pump’s flow rate setting. This 
was repeated again with the probes attached to the syringes in place of the FEP tubing. Results 
were consistent with the pump’s flow rate settings (data not reported). 
 Next, delivery of 1000 µM Succ-(Ala)3-p-NA into 2 mL PBS buffer solutions were 
performed at 1.5, 1.0, and 0.8 µL/min flow rates at 7, 10, and 12.5 min intervals, respectively. 
For this experiment nine buffer solutions were made so that fresh solutions were used for each 
flow rate for each probe. The probes were allowed to equilibrate at the desired flow rate for 15 
minutes prior to dialysate collection so as to flush the probes of previous analyte concentrations. 
Dialysate was collected into empty 1.5 mL microcentrifuge vials for each probe at each flow 
rate.  
The remaining experiments adjusted either enzyme concentration or substrate 
concentration using the same procedure as outlined above for the flow rate manipulations with 
minor variations. In the enzyme manipulation experiment, 1000 µM Succ-(Ala)3-p-NA was 
perfused at 1.5 µL/min into three sets of three 2 mL elastase solutions at 2.0, 1.0, and 0.5 
unit/mL elastase concentrations, made by serial dilution from the Sigma stock, for 7 minutes. 
The substrate manipulation experiment perfused 1000, 500, and 250 µM Succ-(Ala)3-p-NA 
solutions perfused at 1.5 µL/min into three sets of three 2 mL elastase solutions at 1.0 unit/mL 
elastase concentration. In each of these experiments the same equilibration method was used. 
Both experiments were performed at room (21° C) and physiological (37° C) temperature. 
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II. iv. Dialysate Concentration Determination Using NanoDrop Spectrophotometry 
 The dialysate collected from each of the above outlined procedures held enough fluid for 
triplicate 2 µL aliquot readings with some excess if necessary. Each aliquot was measured at 315 
and 380 nm absorbance. These readings were averaged between the three probes and used for the 
following calculations. A system of Beer’s Law equations produced from the calibration curves 
was used to determine the concentration of Succ-(Ala)3-p-NA and p-NA present in the dialysate. 
The concentration of the Succ-(Ala)3-p-NA concentrations loaded into each syringe were also 
collected and measured using the NanoDrop in the same manner. The perfusate and dialysate 
concentrations were then compared to determine EEloss of substrate. 
III. Results and Discussion 
III. i. Absorbance Spectra and Calibration Curves for Analytes 
	 Prior to further experimentation it was necessary to determine the absorbance 
characteristics of the two analytes being measured in these experiments, Succ-(Ala)3-p-NA and 
p-NA. From the prepared 1000 µM samples of either analyte, absorbance spectra were measured 
using the NanoDrop spectrophotometer for both Succ-(Ala)3-p-NA and p-NA. These spectra are 
both displayed overlaid in Figure 4. As can be seen in the diagram, both analytes’ maximum 
absorbance wavelengths partially overlap requiring the expanded Beer’s Law equation discussed 
earlier (Equation 5). Using the maximum wavelengths, 315 nm for Succ-(Ala)3-p-NA and 380 
nm for p-NA, together provides a larger signal for measurement for both analytes, and also offers 












 After determination of the absorbance spectra, the 1000 µM samples of Succ-(Ala)3-p-
NA and p-NA were serially diluted to form a series of standards from which calibration curves 
were constructed using the absorbance measurements at both 315 and 380 nm for both analytes. 
These curves are expressed as Figures 5 and 6 for Succ-(Ala)3-p-NA and p-NA respectively. The 
slopes of these curves represent the molar absorptivity, ε, times the path length as shown by 
Beer’s Law. Since the path length is 1 mm for the NanoDrop 2000c, the slopes of the curves 
were used as the molar absorptivities corresponding to 315 and 380 nm for both Succ-(Ala)3-p-
NA and p-NA that were used for future experiments. These values are displayed in Table 1 and 































As can be seen from the calibration curves, there is a slight, but apparent, overlap in 
absorbance contributions from either analyte at the respective wavelengths. It is because of this 
that the four molar absorptivities displayed in Table 1 will need to be used in conjunction with 
Beer’s Law and the matrix equation shown before (Equation 6) to determine the combined 
dialysate concentrations of each analyte.  
III. ii. Microdialysis Flow Rate Manipulation Results 
 After the calibration curves were developed, microdialysis experiments were performed 
to test the effect on EEloss (Delivery) and product formation under various conditions. The first 
experiment tested the effect flow rate had upon EEloss by eluting 1000 µM Succ-(Ala)3-p-NA 
through three probes to be delivered into triplicate 2 mL sample of 10 mM PBS buffer without 
enzyme present. The dialysate absorbance measurements were then used to determine the Succ-
(Ala)3-p-NA concentration remaining in dialysate. Since no enzyme was present, no p-NA was 
present in the dialysate and a simplified Beer’s Law equation using only the 315 nm molar 
absorptivity was used to calculate the concentration. The results of this experiment are presented 
in Figure 7. The results of this experiment show a decrease in extraction efficiency for 
microdialysis as flow rate increases. This trend is well established in the literature4, 6 occurring 
due to a lower residency time for analytes to successfully diffuse through the semi-permeable 






magnitude the decrease appears linear. However, were the flow rate manipulations increased 
upwards of 5 µL/min a more exponential decrease would likely occur. This experiment was only 
performed at room temperature (21° C), however had it been a higher temperature the extraction 
efficiency would likely be systematically raised at each flow rate due to temperature having a 
proportionate role in determination of diffusion coefficients. Data was not collected to test this 









Though the 1.5 µL/min yielded the lowest EEloss of the three flow rates tested, it was used for all 
subsequent experiments since it yielded quantifiable concentrations of Succ-(Ala)3-p-NA and 
would only need to elute for approximately 7 minutes to provide enough dialysate for triplicate 






III. iii. Microdialysis Enzyme Concentration Manipulation Results 
 While EEloss can be directly manipulated through judicious choice of flow rate, this 
experiment aimed to note the effect that manipulating the concentration of the enzymatic 
solution itself had on EEloss for the microdialysis delivery. To do this, the concentration of 
elastase enzyme present in the solution was adjusted through serial dilution to produce triplicate 
0.5, 1.0, and 2.0 unit/mL elastase solutions in 2 mL centrifuge vials. Following the elution of 
1000 µM Succ-(Ala)3-p-NA into these solutions for 15 minutes of equilibration and 7 minutes of 
collection, the dialysate was analyzed using the NanoDrop spectrophotometer at 315 and 380 




The results of this experiment show that the concentration of the enzyme present in the sampled 
solution has an apparent effect on the EEloss of the microdialysis technique. There is an 
observable positive trend correlated with the extraction efficiency as the sample’s elastase 
concentration increases. What this implies is a stronger delivery of Succ-(Ala)3-p-NA into the 
solution from the microdialysis probe while also producing a stronger p-NA yield due to an 
increase in delivered Succ-(Ala)3-p-NA to react. The product recovery increase is likely further 






























This increased EEloss is likely explained by concentration gradients. In the event of an 
increased enzyme concentration, more active sites remain available to collect the substrate, Succ-
(Ala)3-p-NA. This reduces the apparent concentration of substrate in the solution as compared to 
a lower concentrated enzymatic solution since more substrate is bound as an enzyme-substrate 
complex. Thus this further facilitates the diffusion of Succ-(Ala)3-p-NA into the solution since 
the concentration of the Succ-(Ala)3-p-NA in the solution is reduced faster in the same amount of 
time due to the presence of more enzyme. This in turn, on the other hand, increases the apparent 
concentration of p-NA in solution following the reaction since more substrate can react in the 
same amount of time, further facilitating the diffusion of p-NA into the probe for recovery down 
its now increased concentration gradient. This trend is more apparent in Table 2 by comparing 
the ratio of recovered p-NA to the lost Succ-(Ala)3-p-NA. As the concentration of the elastase 
sample increased so did this ratio. This implies that the rate at which the p-NA is recovered is 
slightly higher than the rate at which the Succ-(Ala)3-p-NA is being delivered, otherwise the 
ratio would decrease as the elastase concentration increased. These experiments were performed 
at room temperature (21° C) and physiological (37° C), and at the higher temperature the data 
appears to show the same trend, however systematically shifted upward likely due to the 
increased activity of the elastase enzyme at its preferred temperature condition. The results of 
this experiment could prove to be useful information since a noticeable trend can be seen to be 
associated with the EEloss of a microdialysis delivery into solutions of increased enzymatic 
concentrations. Normally EEloss is varied by flow rate manipulations by researchers, but the data 




III. iv. Microdialysis Substrate Concentration Manipulation Results 
	 The next experiment tested the effect manipulation of the Succ-(Ala)3-p-NA 
concentration in the perfusate had upon EEloss and p-NA recovery. In this experiment, serially 
diluted concentrations of 250, 500, and 1000 µM Succ-(Ala)3-p-NA were delivered into three 
sets of triplicate 2 mL 1.0 unit/mL solutions of elastase. As before, each concentration of Succ-
(Ala)3-p-NA was eluted for 15 minutes of equilibration and 7 minutes of collection, the dialysate 
of which was analyzed at 315 and 380 nm absorbance wavelengths to determine the 
concentration of p-NA and unreacted Succ-(Ala)3-p-NA. The results of these experiments are 
displayed in Table 3 and Figures 10 and 11. 
 
 
The results of this experiment show a slightly different trend than when the elastase 
concentration was manipulated. From the data presented in Figure 10, it appears that increasing 
the substrate concentration does not have a significant effect on the EEloss of the microdialysis 
delivery method. At each concentration the EEloss remains relatively constant at approximately 
38% for room temperature (21° C) and approximately 56% for physiological (37° C). However, 
it does seem that the physiological 1000 µM EEloss breaks this trend slightly. This may be due to 





















Regardless, manipulating the substrate appears to have little to no effect on the EEloss of 
the delivery. This is likely occurring because the enzyme concentration is not changing. It 
remains at 1.0 unit/mL and thus becomes saturated with Succ-(Ala)3-p-NA faster reducing the 
enhanced diffusion that was suspected in the previous experiment. Without this increased 
diffusion, the delivery thus becomes flow rate dependent likely resulting in the constancy of the 
EEloss. The increased temperature does appear to raise the EEloss systematically by a much higher 
degree than in the previous experiment however. This could also be due to the inconsistent 
temperature readings observed in the lab, but it may also be due to a combined effect the 
temperature has upon the process. The increased temperature will raise the activity of the 
elastase allowing it to facilitate the biochemical reaction faster in the same amount of time, 
encouraging the trend seen in the previous experiment, but also the increased temperature will 
proportionally increase the diffusion coefficients according to Fick’s Law. However, this doesn’t 
explain why the same magnitude of increase was not experienced in the previous experiment. 
Further replications of this experiment are likely necessary to gain a better understanding of this 
phenomenon.  Similarly to the previous experiment, the p-NA concentration increases with Succ-
(Ala)3-p-NA concentration since higher amounts of substrate are able to diffuse into the solution 
if the perfusate is at a higher concentration. The steep slope experienced at the physiological 
temperature suggests that this reaction is substrate limited and has not yet approached Michaelis-
Menten equilibrium. However, the lower temperature appears to have begun to plateau 
suggesting an enzyme limitation. While an increase in the EEloss was not observed, a much larger 
magnitude of recovered product was achieved between substrate concentrations. This could be 
useful in artificially boosting the analyte signal for measuring the activity of an enzyme in 
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question by encouraging a stronger product output by increasing the substrate eluted to facilitate 
the reaction. 
IV. Conclusion 
 Microdialysis could prove to be both a viable and useful method for instigating 
biochemical reactions in vitro. The experiments reinforced literature observations linking 
increased flow rates to decreased extraction efficiencies, further extablishing the need to use low 
flow rates to achieve the highest resolution of results. The results of the experiments further 
suggested that the extraction efficiency of the microdialysis delivery method is linked to the 
activity of the enzyme in the solution, increasing the effectiveness of the delivery itself and the 
output of product. This conclusion appears further supported by the absence of this trend when 
adjusting the Succ-(Ala)3-p-NA concentrations instead. Some problems arose when trying to 
raise the temperature of the solutions to physiological ranges due to observed uneven heating that 
could have potentially skewed several of the results in this paper. To correct this, further 
replicative experiments should be performed to determine if these were out of character results. 
This could potentially be translated towards monitoring in vivo systems as a means of sampling 
enzymatic processes. However, much more work will be necessary to account for increased 
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